PMDA drug package insert
チラーヂンS静注液200μg
PMDA Prescription drug · あすか製薬株式会社 · package insert Apr 28, 2021
Key facts
| Brand names | チラーヂンS静注液200μg |
|---|---|
| Nonproprietary names | レボチロキシンナトリウム水和物 |
| Companies | 製造販売元／あすか製薬株式会社, 販売元／武田薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 甲状腺ホルモン製剤 |
| Therapeutic category codes | 872431 |
| YJ codes | 2431400A1029 |
| Approval numbers | 30200AMX00023 |
| Package insert edition | 第1版 |
| Package insert date | Apr 28, 2021 |
| PMDA document key | 470007_2431400A1029_1 |
| PMDA company code | 470007 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: